News

Optis v Apple [2021] EWHC 2564 (Pat)27 September 2021Mr Justice Meade handed down judgment in the third trial of these proceedings. Isabel Jamal and Jennifer Dixon acted for Optis together with Sarah Ford QC and were instructed by EIP. The Judgment is available here.
Optis v Apple [2021] EWHC 2564 (Pat)27 September 2021Isabel Jamal and Jennifer Dixon appeared for the Claimants (“Optis”), with Isabel as the lead advocate on the FRAND parts of the case and Sarah Ford QC as the lead advocate on the competition law parts of the case, in a trial determining whether or not the Defendants (“Apple”) were entitled to rely on Optis’ […]
10,000 Black Interns Programme10 September 2021Chambers is delighted to announce that it has committed to host an intern on a shared basis with other contributing chambers, law firms and the judiciary as part of the Bar’s collective participation in the #10000BlackInterns Scheme. The 10,000 Black Interns Programme aims to transform the horizons and prospects of young Black people in the […]
Michael Tappin QC and Charlotte May QC appointed as Deputy High Court Judges6 September 2021Chambers is very pleased to announce that Michael Tappin QC and Charlotte May QC have been appointed as Deputy High Court Judges, sitting in the Chancery Division. Chambers wish them both every success in their new appointments.  
Advanced Bionics v Med-El Elektromedizinische Gerate31 August 2021Andrew Lykiardopoulos QC led the counsel team for the claimants, Advanced Bionics, in this successful application for expedition of a patent trial.  The patent, held by the defendant, Med-El, is entitled ‘MRI-Safe Disk Magnet for Implants’ and has particular application for cochlear implants.  Advanced Bionics seeks to invalidate the patent and/or to establish that Advanced […]
FibroGen and Astellas Pharma v Akebia and Otsuka24 August 2021Michael Conway acted on the counsel team for Astellas, one of the appellants in this appeal against the judgment of Lord Justice Arnold in [2020] EWHC 866 (Pat) concerning six patents in two families (referred to as Family A and Family B). The Patents claimed the use of compounds with broadly defined structural features that […]
Liverpool Gin Distillery and Halewood v Sazerac5 August 2021Daniel Alexander QC and Maxwell Keay acted for the respondents, Sazerac, in this unsuccessful appeal against a finding that the appellant, Halewood, had infringed Sazerac’s trade marks.  Sazerac owns two trade marks consisting of the words EAGLE RARE in respect of whisky in class 33.  Halewood had launched a Tennessee straight bourbon whiskey under the […]
Welcome Speeches for Mr Justice Mellor2 August 2021Please click here to see Welcome speeches for Mr Justice Mellor.
Dr Reddy’s Laboratories, Actavis et al v Warner-Lambert & Pfizer30 July 2021This was a trial of preliminary issues in a combined action of claims by numerous parties for compensation following from the pregabalin/Lyrica litigation which culminated in the Supreme Court judgment Warner-Lamber v Generics (UK) Ltd (t/a Mylan) [2018] UKSC 56.  Andrew Lykiardopoulos QC acted for Actavis and Teva, two of the claimants, and Charlotte May […]
InterDigital v Lenovo29 July 2021Maxwell Keay acted in the counsel team for the claimants, Interdigital, in this patent trial.  This technical trial was the first in a series of trials concerning five patents in the field of 3G and 4G telecommunications, with further technical trials and a FRAND trial due to follow.  This trial concerned European Patent (UK) No […]